Related Experiment Video
Updated: Mar 28, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Tumor suppressor RIZ1 in obesity and the PI3K/AKT/mTOR pathway
Xiaolei Xie1, Xian Man1, Zuobin Zhu1
1State Key Lab of Medical Genetics, Xiangya Medical School, Central South University, Changsha, China.
Objective:
The aim of this study was to investigate the shared molecular pathways of obesity and cancer by exploring the role of RIZ1 in obesity and the phospatidylinositol 3-kinase (PI3K)/V-Akt murine thymoma viral oncogene homolog (PKB) (AKT)/mechanistic target of rapamycin (mTOR) pathway.
Methods:
Male wild type (WT) and Riz1(-/-) mice (KO) were fed a standard diet (STD) or a high-fat (HF) diet for up to 8 months. These mice were studied for phenotypic and molecular changes.
Results:
Riz1(-/-) mice gained more weight on a HF diet compared to WT mice, with higher free fatty acid and increased visceral fat. Metabolic cage analysis of Riz1(-/-) mice showed lower oxygen consumption but no changes in food intake and ambulatory activity. Riz1(-/-) mice showed impaired glucose regulation but no change in insulin sensitivity. RNA-seq and quantitative RT-PCR analysis found altered expression in certain glycolysis and ATP production genes such as Ubiad1, Atp5g2, and Cyp4a12. The PI3K/AKT/mTOR pathway was activated in the Riz1(-/-) mice fed a HF diet with higher Akt3 mRNA levels and increased phosphorylation of AKT (Ser473), mTOR, and S6.
Conclusions:
The results identify RIZ1 as an important regulator of both Akt3 transcription and AKT phosphorylation and suggest a role for RIZ1 in HF-induced obesity and the AKT pathway.
Insights
RIZ1 deficiency exacerbates high-fat diet-induced obesity by altering energy metabolism and activating the PI3K/AKT/mTOR pathway. This highlights RIZ1
Area of Science:
- Molecular biology
- Metabolic research
- Obesity and cancer research
Background:
- Obesity and cancer share common molecular pathways.
- The phosphatidylinositol 3-kinase (PI3K)/V-Akt murine thymoma viral oncogene homolog (PKB) (AKT)/mechanistic target of rapamycin (mTOR) pathway is implicated in both conditions.
- The role of RIZ1 in obesity and its connection to the PI3K/AKT/mTOR pathway requires further investigation.
Purpose of the Study:
- To investigate the role of RIZ1 in high-fat diet-induced obesity.
- To explore the involvement of the PI3K/AKT/mTOR pathway in RIZ1-mediated metabolic changes.
- To understand the shared molecular mechanisms between obesity and cancer.
Main Methods:
- Male wild type (WT) and RIZ1 knockout (KO) mice were fed standard or high-fat diets for 8 months.
- Phenotypic changes, including weight gain and body composition, were assessed.
- Molecular analyses included RNA sequencing, quantitative RT-PCR, and Western blotting to examine gene expression and protein phosphorylation within the PI3K/AKT/mTOR pathway.
Main Results:
- Riz1(-/-) mice exhibited increased weight gain, visceral fat accumulation, and impaired glucose regulation on a high-fat diet.
- Lower oxygen consumption was observed in Riz1(-/-) mice, indicating altered energy metabolism.
- Activation of the PI3K/AKT/mTOR pathway, evidenced by increased Akt3 mRNA and AKT/mTOR/S6 phosphorylation, was observed in Riz1(-/-) mice on a high-fat diet.
Conclusions:
- RIZ1 is identified as a key regulator of Akt3 transcription and AKT phosphorylation.
- RIZ1 plays a significant role in high-fat diet-induced obesity.
- The study suggests a link between RIZ1, obesity, and the AKT signaling pathway, potentially relevant to shared cancer mechanisms.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

